Notably, placentas from flutamide‐mice displayed a transcriptional profile indistinguishable from that of control mice at both at E10.5 and E13.5 (Figure 2a; Figure S2a, Supporting Information), indicating that the inhibition of the androgen receptor safeguarded against the transcriptional perturbation observed in PCOS‐mice. Here, AR is linked to polycystic ovary syndrome.